Go Pro
NASDAQ:NVOS

Novo Integrated Sciences (NVOS) Stock Price, News & Analysis

$0.0039 0.00 (0.00%)
As of 09/28/2026 01:13 PM Eastern

About Novo Integrated Sciences Stock (NASDAQ:NVOS)

Advanced

Key Stats

Today's Range
$0.0006
▼
$0.0039
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.06
Volume
1,104 shs
Average Volume
7,459 shs
Market Capitalization
$76.95 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novo Integrated Sciences, Inc. is a healthcare company focused on delivering integrated medical services and developing healthcare-related products and technologies. Its business has included multidisciplinary primary care, rehabilitation, chronic disease management, diagnostic services and telehealth solutions designed to support patients across different stages of care.

The company has operated through healthcare clinics and affiliated providers, primarily in Canada, and has also pursued opportunities involving medical devices, digital health and remote-care technologies. Its service model is intended to connect physicians, rehabilitation professionals and other healthcare practitioners while improving access to coordinated care.

Novo Integrated Sciences has also explored strategic acquisitions, partnerships and technology initiatives to expand its healthcare platform. Robert W. Mattacchione has served as the company’s chairman and chief executive officer. The company’s operations and strategic focus may change as it develops its healthcare services and commercializes related products.

AI Generated. May Contain Errors.

Receive NVOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVOS Stock News Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More Headlines

NVOS Stock Analysis - Frequently Asked Questions

Novo Integrated Sciences' stock was trading at $0.0027 on January 1st, 2026. Since then, NVOS shares have increased by 44.4% and is now trading at $0.0039.

Novo Integrated Sciences shares reverse split on the morning of Tuesday, November 7th 2023.The 1-10 reverse split was announced on Tuesday, November 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of NVOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novo Integrated Sciences investors own include AMC Entertainment (AMC), Sangamo Therapeutics (SGMO), NIO (NIO), Biora Therapeutics (BIOR), Tesla (TSLA).

Company Calendar

Today
9/29/2026
Fiscal Year End
8/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
NASDAQ:NVOS
CIK
1138978
Fax
N/A
Employees
115
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
($0.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.17 million
Net Margins
-121.55%
Pretax Margin
-121.32%
Return on Equity
-93.07%
Return on Assets
-46.28%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
0.37
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$13.52 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.77 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
19,730,000
Free Float
17,678,000
Market Cap
$76.95 thousand
Optionable
Not Optionable
Beta
5.79

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:NVOS) was last updated on 9/29/2026 by MarketBeat.com Staff.
From Our Partners